RxDoctor Payments Data

Abelardo Rodriguez, MD

Family Medicine · San Antonio, TXNPI 1366586190

Payments from drug & device makers

$1,914in general payments, 2019–2025

Across 30 payments — averaging $63.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$403
  • Bayer$390
  • Amarin Pharma, Inc.$250
  • Lilly USA, LLC$218
  • Novo Nordisk$211
  • AbbVie$178
  • plus $263 from 4 others

What the payments were for

  • Food & beverage$1,914100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,914 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$96,817
Medicare patients
294
Services billed
1,200

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin53$72,456
OzempicSemaglutide42$54,426
EliquisApixaban41$48,008
FarxigaDapagliflozin Propanediol49$42,786
MounjaroTirzepatide28$31,930
RybelsusSemaglutide18$31,906
TrulicityDulaglutide30$30,994
TradjentaLinagliptin43$30,230
JanuviaSitagliptin Phosphate21$29,958
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$18,900
MyrbetriqMirabegron12$14,399
Xigduo XrDapaglifloz Propaned/Metformin13$14,300
VascepaIcosapent Ethyl18$10,902
Janumet XrSitagliptin Phos/Metformin Hcl11$9,209
JanumetSitagliptin Phos/Metformin Hcl12$6,710

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$211$86,33260 claims
Lilly USA, LLCMounjaro, Trulicity$218$62,92458 claims
AstraZenecaFarxiga$403$42,78649 claims
GSKTrelegy Ellipta$113$18,90017 claims
AbbVieSynthroid$178$1,56324 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,760 family medicine providers in Texas.

Other family medicine in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →